CN1030373C - Medicine for treating lumbar arthralgia - Google Patents
Medicine for treating lumbar arthralgia Download PDFInfo
- Publication number
- CN1030373C CN1030373C CN93102774A CN93102774A CN1030373C CN 1030373 C CN1030373 C CN 1030373C CN 93102774 A CN93102774 A CN 93102774A CN 93102774 A CN93102774 A CN 93102774A CN 1030373 C CN1030373 C CN 1030373C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- wood
- cortex
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 229940079593 drug Drugs 0.000 title claims description 5
- 208000006820 Arthralgia Diseases 0.000 title 1
- 241000218176 Corydalis Species 0.000 claims abstract description 6
- 239000004863 Frankincense Substances 0.000 claims abstract description 6
- 239000002023 wood Substances 0.000 claims abstract description 6
- 239000002775 capsule Substances 0.000 claims abstract description 5
- 210000000582 semen Anatomy 0.000 claims description 10
- 241000972155 Moschus Species 0.000 claims description 6
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 5
- 241000717739 Boswellia sacra Species 0.000 claims description 5
- 241000756943 Codonopsis Species 0.000 claims description 5
- 241000628997 Flos Species 0.000 claims description 5
- 241000237903 Hirudo Species 0.000 claims description 5
- 241001057584 Myrrha Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 241000237636 Pheretima Species 0.000 claims description 5
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 5
- 239000009286 sanguis draxonis Substances 0.000 claims description 5
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 208000002193 Pain Diseases 0.000 abstract description 7
- 206010025005 lumbar spinal stenosis Diseases 0.000 abstract description 7
- 210000005036 nerve Anatomy 0.000 abstract description 7
- 208000005198 spinal stenosis Diseases 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 206010030113 Oedema Diseases 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 239000002552 dosage form Substances 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 244000306301 Caesalpinia sappan Species 0.000 abstract 1
- 235000015162 Caesalpinia sappan Nutrition 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 230000000740 bleeding effect Effects 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 239000003925 fat Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 244000138993 panchioli Species 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 208000012287 Prolapse Diseases 0.000 description 7
- 230000023597 hemostasis Effects 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- -1 wind Chemical compound 0.000 description 2
- 206010002942 Apathy Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000003164 cauda equina Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese patent medicine for curing lumbar disc herniation and lumbar spinal stenosis. The medicine is prepared from multiple Chinese herbal medicines such as pseudo-ginseng, safflower, dalbergia wood, dragon's blood, sappan wood, frankincense, myrrh, corydalis tuber, musk and the like, and can be prepared into tablets, granules, capsules, external paste and other dosage forms. After the medicine acts on a human body, the medicine eliminates inflammation stimulation such as congestion, edema and the like of nerve roots, stops bleeding, relieves pain, relieves the intraspinal pressure, eliminates clinical symptoms and cures diseases. Has effects in promoting blood circulation, dispelling blood stasis, dredging channels and fats, regulating function, strengthening waist, and invigorating kidney.
Description
The present invention relates to a kind of medicine for the treatment of prolapse of lumbar intervertebral disc and lumbar spinal stenosis.
Modern medicine is thought, the cause of disease of prolapse of lumbar intervertebral disc is more, but its mechanism is because the outthrust of intercalated disc stimulates, pressuring neural root, makes the nerve root of pressurized, the acute injury inflammatory reaction takes place in early days, be congested, edema, abnormal phenomenas such as chap, correct if can not in time obtain, the nerve root place then sticks together, and degeneration and atrophy make its motion of domination district and sensory deprivation.
Lumbar spinal stenosis also is owing to hypertrophy or displacement, and causes luminal stenosis that compressing cutter coccygeal nerve or nerve root the hyperemia of nerve root also take place, edema, phenomenons such as chap with regard to its mechanism.Therefore these two kinds of diseases be referred to ass the waist arthromyodynia in tcm theory, and its basic reason is because of positive deficiency of vital energy sense, and wind-engaging such as fills in, wet at exopathogen, causes qi and blood disorder, and meridians muscle arteries and veins is obstructed.So stagnation of QI and blood may bring about pain can not then apathy of nourishing muscle and tendon.
For these two kinds of diseases of treatment, generally based on the treatment of conservative approach such as massage, traction and physical therapy, the surgical operation therapy of passing through is arranged also now.But expectant treatment is long the course of treatment, and cure rate is low, operative treatment then often the patient have and refuse to be afraid of psychology, only at a puss, just selection.In addition, these type of diseases of treatment such as oral drugs are flat as: ibuprofen, wind, ibuprofen are also arranged at present.Yet because this class medicine belongs to the medicine of treatment myalgia, pain that can only reduction of patient is so can not cure prolapse of lumbar intervertebral disc and lumbar spinal stenosis isosceles arthromyodynia effectively.Chinese Traditional Medicines for oral administration for adopting Chinese herbal medicine to make then more do not have report.
The objective of the invention is according to the theory of traditional Chinese medical science waist arthromyodynia select suitable to invigorate blood circulation, blood stasis dispelling, the kidney invigorating class Chinese herb medicine prescription make medicine for waist rheumatism, to realize the therapeutic purposes to prolapse of lumbar intervertebral disc and lumbar spinal stenosis isosceles arthromyodynia, removes patient's slight illness.
Purpose of the present invention can realize by following proposal.
Include following Chinese herb medicine in the medicine for waist rheumatism of the present invention, and the weight portion ratio of various medicines is:
Flos Carthami 1-15;
Lignum Sappan 1-20;
Olibanum 0.5-10;
Myrrha 0.5-10;
Radix Sanguisorbae 1-10;
Pollen Typhae 1-5;
Radix Notoginseng 1-15;
Herba Lycopi 1-10;
Sanguis Draxonis 1-20;
Lignum Dalbergiae Odoriferae 1-15;
Rhizoma Corydalis 1-15;
Moschus 0.02-1;
Semen Strychni 1-20;
Rhizoma Atractylodis Macrocephalae 10-20;
Cortex Eucommiae 2-10;
Cortex Cinnamomi 1-10;
Petiolus Trachycarpi 1-6;
The 1-10 of Radix Et Rhizoma Rhei;
Hirudo 0.5-9;
Pheretima 1-10;
Radix Codonopsis 1-10;
Fructus Amomi 1-8;
Fructus Aurantii Immaturus 1-6;
Cortex Magnoliae Officinalis 1-6;
Borneolum Syntheticum 0.4-3;
Cinnabaris 0.5-4;
Semen Ziziphi Spinosae 1.3-10;
Herba Saxifragae 1-8;
Radix Achyranthis Bidentatae 1-10.
Medicine for waist rheumatism of the present invention can be used the common process manufacture method, makes various dosage forms for oral administration, as tablet, capsule, electuary etc., can also make external application paste.
Chinese herb medicine among the present invention:
Radix Notoginseng, Flos Carthami, Lignum Dalbergiae Odoriferae, Sanguis Draxonis, Lignum Sappan, Olibanum, Myrrha, Rhizoma Corydalis, Hirudo, Pheretima have the effect of blood circulation promoting and blood stasis dispelling, dredging the meridian and hemostasis analgesic therapy;
Radix Achyranthis Bidentatae is that priming is descending;
Petiolus Trachycarpi,
Wood, Herba Saxifragae, Radix Sanguisorbae, Pollen Typhae have the anastaltic effect of removing heat from blood;
Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Fructus Aurantii Immaturus, Fructus Amomi are used to transfer regulating the function of middle-JIAO;
Radix Et Rhizoma Rhei are used for the intestines and stomach coordinating, relieving constipation pathogenic fire purging, and auxiliary blood circulation promoting and blood stasis dispelling;
Semen Ziziphi Spinosae, pearl sand is in order to tranquilizing by nourishing the heart, and the merit of detoxifcation is arranged;
Cortex Cinnamomi, the Cortex Eucommiae are in order to warming and recuperating the kidney-YANG;
Semen Strychni is in order to activating collaterals to relieve pain;
The Herba Lycopi in order to invigorate blood circulation, blood stasis dispelling, diuresis detumescent;
Moschus divides stagnant in order to promoting the circulation of blood, blood circulation promoting and dispersing pathogen accumulation, reducing swelling and alleviating pain;
Moschus and Borneolum Syntheticum also have the effect of having one's ideas straightened out in addition.
The all medicine compatibility of the present invention uses and gathers blood circulation promoting and blood stasis dispelling altogether, dredging the meridian, regulative mechanism, and hemostasis, detumescence, pain relieving and strengthening vital energy of kidney.It can be after effect be human body, by eliminating nerve root hyperemia, and inflammatory stimulus such as edema, thus alleviate intraspinal pressure, make clinical symptom disappearance, cure sufferer.
The present invention is through clinical verification, and this medical instrument has good invigorating blood circulation, the effect of blood stasis dispelling, hemostasis, pain relieving, kidney warming and yang invigorating.
Took medicine 1-3 month through the patient, and to the pertinent regulations of prolapse of lumbar intervertebral disc, the result of evaluation curative effect is according to " the clinical research guideline of new drug (Chinese medicine) treatment lumbago and skelalgia ":
1. prolapse of lumbar intervertebral disc: treat 68 examples altogether, cure 57 examples; Produce effects 8 examples.
2. lumbar spinal stenosis: treat 46 examples altogether, cure 38 examples; Produce effects 5 examples.
In addition, this medicine not only can be used for treatment and cures prolapse of lumbar intervertebral disc and lumbar spinal stenosis, for the outstanding compressing of central type cauda equina nerve the patient is arranged, and also can obtain obvious therapeutic effect, and, also have treatment and auxiliary treatment effect for diseases such as lumbar sprain, lumbar muscle strain and sciatica.
Below provide the medicine for waist rheumatism formulation Example of the various dosage forms of the present invention.
Tablet 1 tablet 2 tablets 3 electuaries 1 electuary 2
(1) Flos Carthami 4 2.7 344
(2) Lignum Sappan 1.7 1.8 1.5 32
(3) Olibanum 1 1.6 1.3 1.5 1.5
(4) Myrrha 1 1.6 1.3 1.5 1.5
(5) Radix Sanguisorbae 1.8 1.8 3.8 3 1.4
(6) Pollen Typhae 1.5 1.3 2.7 3 1.4
(7) Radix Notoginseng 1.3 1.9 1.2 3.2 1.2
(8) Herba Lycopi 1.2 12 1.8 1.5
(9) Sanguis Draxonis 5 3.5 1.5 2 2.2
(10) Lignum Dalbergiae Odoriferae 2 2.5 1.2 3 1.8
(11) Rhizoma Corydalis 142 2.5 10
(12) Moschus 0.4 0.03 0.02 0.04 0.06
(13) Semen Strychni 2.5 4.5 1.5 32
(14) Rhizoma Atractylodis Macrocephalae 4 2.6 1.5 32
(15) Cortex Eucommiae 2 2.1 216
(16) Cortex Cinnamomi 1.5 1.8 1.5 13
(17) Petiolus Trachycarpi 13 1.5 2.4 1.25
(18) Radix Et Rhizoma Rhei 1.5 2.1 12 1.5
(19) Hirudo 3 1.5 12 1.2
(20) Pheretima 1.3 1.6 42 1.2
(21) Radix Codonopsis 2 2.1 12 1.5
(22) Fructus Amomi 1.5 1.8 1.2 1.5 1.5
(23) Fructus Aurantii Immaturus 1 1.4 1.1 1.5 1.5
(24) Cortex Magnoliae Officinalis 1.2 1.5 1 1.5 1.2
(25) Borneolum Syntheticum 0.4 0.4 0.6 11
(26) Cinnabaris 0.9 0.9 0.8 0.6 1.2
(27) Semen Ziziphi Spinosae 22 1.3 1.3 2
(28)
Wood 2 1.6 223
(29) Herba Saxifragae 2.2 1.7 314
(30) Radix Achyranthis Bidentatae 1.2 9 1.5 22
Capsule 1 capsule 2 plaster 1 plaster 2
(1) Flos Carthami 337 10
(2) Lignum Sappan 1.5 1.2 64
(3) Olibanum 2 0.9 10 6
(4) Myrrha 2 0.9 10 6
(5) Radix Sanguisorbae 1 1.2 5 10
(6) Pollen Typhae 1125
(7) Radix Notoginseng 1.5 253
(8) Herba Lycopi 4387
(9) Sanguis Draxonis 3 1.7 46
(10) Lignum Dalbergiae Odoriferae 3 1.5 36
(11) Rhizoma Corydalis 3257
(12) Moschus 0.02 0.1 0.05 0.2
(13) Semen Strychni 2435
(14) Rhizoma Atractylodis Macrocephalae 32 10 12
(15) Cortex Eucommiae 4358
(16) Cortex Cinnamomi 22 4.5 5
(17) Petiolus Trachycarpi 5 1.2 65
(18) Radix Et Rhizoma Rhei 3 1.5
(19) Hirudo 2.4 145
(20) Pheretima 1.8 1.5 44
(21) Radix Codonopsis 2.5 2
(22) Fructus Amomi 3 1.5
(23) Fructus Aurantii Immaturus 1.5 1.4
(24) Cortex Magnoliae Officinalis 1.5 1.4
(25) Borneolum Syntheticum 0.8 0.4 31
(26) Cinnabaris 0.6 0.7
(27) Semen Ziziphi Spinosae 32
(28)
Wood 1.5 1.8 51
(29) Herba Saxifragae 32 6.5 3
(30) Radix Achyranthis Bidentatae 1.5 445
Claims (2)
1, a kind of medicine medicine for waist rheumatism is characterized in that the Chinese herb medicine that it comprises and the weight portion ratio of various medicines are:
Flos Carthami 1-15;
Lignum Sappan 1-20;
Olibanum 0.5-10;
Myrrha 0.5-10;
Radix Sanguisorbae 1-10;
Pollen Typhae 1-5;
Radix Notoginseng 1-15;
Herba Lycopi 1-10;
Sanguis Draxonis 1-20;
Lignum Dalbergiae Odoriferae 1-15;
Rhizoma Corydalis 1-15;
Moschus 0.02-1;
Semen Strychni 1-20;
Rhizoma Atractylodis Macrocephalae 10-20;
Cortex Eucommiae 2-10;
Cortex Cinnamomi 1-10;
Petiolus Trachycarpi 1-6;
The 1-10 of Radix Et Rhizoma Rhei;
Hirudo 0.5-9;
Pheretima 1-10;
Radix Codonopsis 1-10;
Fructus Amomi 1-8;
Fructus Aurantii Immaturus 1-6;
Cortex Magnoliae Officinalis 1-6;
Borneolum Syntheticum 0.4-3;
Cinnabaris 0.5-4;
Semen Ziziphi Spinosae 1.3-10;
Wood 1-10;
Herba Saxifragae 1-8;
Radix Achyranthis Bidentatae 1-10.
2,, it is characterized in that it can make tablet for oral administration, capsule, electuary and externally used paste according to the described medicine for waist rheumatism of claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93102774A CN1030373C (en) | 1993-03-27 | 1993-03-27 | Medicine for treating lumbar arthralgia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN93102774A CN1030373C (en) | 1993-03-27 | 1993-03-27 | Medicine for treating lumbar arthralgia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1079661A CN1079661A (en) | 1993-12-22 |
| CN1030373C true CN1030373C (en) | 1995-11-29 |
Family
ID=4984286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN93102774A Expired - Fee Related CN1030373C (en) | 1993-03-27 | 1993-03-27 | Medicine for treating lumbar arthralgia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1030373C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1049585C (en) * | 1994-01-27 | 2000-02-23 | 安占全 | Medicine for treatment of lumbar intervertebral disc protrusion |
| DE4444288A1 (en) * | 1994-12-13 | 1996-06-20 | Rainer Dr Med Etzel | Use of frankincense to treat Alzheimer's disease |
| CN1052651C (en) * | 1996-09-17 | 2000-05-24 | 姚永全 | Gujinkang traditional Chinese medicine and preparation method |
-
1993
- 1993-03-27 CN CN93102774A patent/CN1030373C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1079661A (en) | 1993-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1167454C (en) | Chinese medicine for detoxication purpose and its preparing process | |
| CN1171599C (en) | Plaster for treating pain in neck, shoulder, waist and leg and its prepn process | |
| CN1288748A (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
| CN1745801A (en) | Ointment for treating spur | |
| CN1283309C (en) | Pure medicinal liquor | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1111043C (en) | Medicine for protrusion of lumber vertebral disc and its preparation | |
| CN1256969C (en) | Chinese medicine for treating bone disease and its preparation | |
| CN1030373C (en) | Medicine for treating lumbar arthralgia | |
| CN101961434A (en) | Rheumatic Xintong powder | |
| CN1181868C (en) | Chinese medicine prepn for treating obliterans thromboangitis | |
| CN1059105C (en) | Bi Syndrome curing medicine | |
| CN1478521A (en) | Medicine for relaxing muscles and tendons and activiating colleterals and pain dispelling | |
| CN1122242A (en) | Medicinal powder for rheumatoid disease | |
| CN1086586C (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
| CN1186067C (en) | Medicine for curing acute injury of muscle and tendon and its preparation method | |
| CN1663577A (en) | Chinese medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN1055862C (en) | Chinese medicine preparation for curing osteonecrosis | |
| CN1290548C (en) | Traditional Chinese medicine for curing bone fracture and rheumatic diseases | |
| CN1186074C (en) | Chinese medicinal proprietary for treating hemiplegic by apoplexia-Fuzhengpiantanwan | |
| CN1256102C (en) | Powder for treating hyperosteogeny and protrusion of lumber and spondylopathy intervertebral disc and its preparation | |
| CN1872310A (en) | Preparation of Chinese traditional medicine for treating hyperosteogeny | |
| CN1686467A (en) | Zuanshanfeng wind damp oil and its preparation method | |
| CN1158099C (en) | Medicine for treating osteoarthritis and its preparing process and application | |
| CN1481863A (en) | Chinese traditional medicine for deafness and tinnitus and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |